EXAI vs. IBB

Last updated Jun 4, 2026

EXAI (Exscientia Ltd ADR) is a stock, while IBB (iShares Nasdaq Biotechnology ETF) is Health & Biotech Equities fund tracking the NASDAQ Biotechnology Index. At a 0.34 correlation, their price movements are largely independent.

Performance

EXAI vs. IBB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Exscientia Ltd ADR (EXAI) and iShares Nasdaq Biotechnology ETF (IBB). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

EXAI

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

IBB

• 1D: 1.97%
• 1M: -1.56%
• YTD: -0.68%
• 6M: -2.57%
• 1Y: 34.50%
• 3Y*: 9.40%
• 5Y*: 2.10%
• 10Y*: 6.23%

*Multi-year figures are annualized to reflect compound growth (CAGR)

EXAI vs. IBB - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
EXAI Exscientia Ltd ADR	0.00%	0.00%	-24.49%	20.26%	-73.03%	-27.08%
IBB iShares Nasdaq Biotechnology ETF	-0.68%	27.98%	-2.41%	3.76%	-13.69%	-3.94%

Correlation

The correlation between EXAI and IBB is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (3Y) Calculated over the trailing 3-year period	0.27
Correlation (All Time) Calculated using the full available price history since Oct 4, 2021	0.34

Return for Risk

EXAI vs. IBB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBB

IBB Risk / Return Rank: 56
IBB Sharpe Ratio Rank: 50
IBB Sortino Ratio Rank: 50
IBB Omega Ratio Rank: 46
IBB Calmar Ratio Rank: 71
IBB Martin Ratio Rank: 62

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EXAI vs. IBB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Exscientia Ltd ADR (EXAI) and iShares Nasdaq Biotechnology ETF (IBB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	EXAI	IBB	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.74	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.10	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.27	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	0.26	—

Drawdowns

Drawdown Indicators

	EXAI	IBB	Difference
Max Drawdown Largest peak-to-trough decline	—	-62.85%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-9.63%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-24.85%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-39.82%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-39.82%	—
Current Drawdown Current decline from peak	—	-5.64%	—
Average Drawdown Average peak-to-trough decline	—	-21.18%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	3.03%	—

Volatility

Volatility by Period

	EXAI	IBB	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	6.86%	—
Volatility (6M) Calculated over the trailing 6-month period	—	15.38%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	19.89%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	21.99%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	23.22%	—

Dividends

EXAI vs. IBB - Dividend Comparison

EXAI has not paid dividends to shareholders, while IBB's dividend yield for the trailing twelve months is around 0.23%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
EXAI Exscientia Ltd ADR	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
IBB iShares Nasdaq Biotechnology ETF	0.23%	0.23%	0.29%	0.26%	0.31%	0.21%	0.21%	0.33%	0.20%	0.30%	0.19%	0.03%

Frequently Asked Questions

Can I hold both EXAI and IBB in my portfolio?

EXAI and IBB have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.